All who are involved in research, counseling, screening, diagnosis, treatment or prevention of hereditairy breast and ovarium cancer are welcome.
This year’s program will feature some extras: many years of collaboration of Hebon in IBCCS has resulted in some exciting findings on the impact of lifestyle and risk factors on risk assessment that will be presented by invited speakers from Great Britain , France and the USA. Two new related studies from Canada and the USA will also be presented.
3521 AL Utrecht
Do you have questions or comments, please contact:
Denise Jenner: email@example.com
Phone: 020 512 2484
RT @imvanlangen: (Ook) verkeerde uitslag gentest verandert lichaam en geest, door placebo effect, laat wetenschappelijk onderzoek zien. ht…